There is abundant published evidence associating the CDC73 gene with hyperparathyroidism-jaw tumor syndrome, since the gene-disease relationship was first proposed by Carpten et al. (2002). Multiple case level studies have been performed with HPT-JT patients that have variants in the CDC73 gene. Loss of nuclear expression and immunoreactivity of Parafibromin was reported in Parathyroid Carcinoma of HPT-JT patients. Functional characterization of three mutations from CDC73 patients caused cell overgrowth in cell proliferation assay. CDC73 deficient mice (Both Cdc73+/− mice and the conditional Cdc73+/L/PTH- Cre and Cdc73L/L/PTH-Cre mice) develop parathyroid and uterine tumours. All of these types of evidence are consistent with a definitive relationship between the CDC73 gene and hyperparathyroidism-jaw tumor syndrome.
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.